Suven Pharmaceuticals receives credit ratings from CRISIL
Suven Pharmaceuticals announced that CRISIL has assigned the following ratings to the bank facilities of the company.
Facilities Rating Long term bank facilitiesCRISIL A+/ Watch Developing (placed on rating watch with developing implications)
Short term bank facilities CRISIL A1+/ Watch Developing (placed on rating watch with developing implications)Powered by Capital Market - Live News
Disclaimer: No Business Standard Journalist was involved in creation of this content